NHS Patient Safety Alerts

Supplements NatPSA/2024/007/DHSC. Continued limited Creon supplies through 2026.

Shortage of Mo-99/Tc-99m generators used in nuclear medicine diagnostic imaging.

Kay-Cee-L discontinuing late November 2024. Supersedes NatPSA/2024/008/DHSC.

Cease pre-preparing oxytocin infusions at ward level. Higher postnatal dose accidentally given before birth harms mother and infant.

Limited Human Albumin stock July-December 2024. Prioritise for critical patients.

Impending Kay-Cee-L shortage from late September 2024. Superseded by NatPSA/2024/011/DHSC.

Limited Creon 10,000 and 25,000 capsule supplies with constraints until 2026.

Supply shortage of Orencia ClickJect (abatacept) pre-filled pens for rheumatoid arthritis.

Supply shortage of Erelzi (etanercept) pre-filled pens for autoimmune conditions.

TACO caused 111 deaths (39.2% of transfusion fatalities) 2010-2022. Implement risk assessments and staff training.

Supply shortage of salbutamol nebuliser liquid unit dose vials.

Replace Luer connectors with NRFit for intrathecal/epidural procedures to prevent fatal wrong-route administration.

GLP-1 RA supply not expected to normalise until at least end of 2024. Supersedes NatPSA/2023/008/DHSC.